Dr Faheem Mohammed Haq, MD | |
1901 N Macarthur Blvd, Irving, TX 75061-2220 | |
(972) 579-8485 | |
Not Available |
Full Name | Dr Faheem Mohammed Haq |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 16 Years |
Location | 1901 N Macarthur Blvd, Irving, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437455086 | NPI | - | NPPES |
08833361 | Medicaid | MS | |
2162535 | Medicaid | LA |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White Medical Center At Irving | Irving, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.
Researchers have found that children with achromatopsia have milder foveal pathology than their older counterparts, highlighting a potential opportunity for early intervention with gene therapy.
Allos Therapeutics, Inc. today announced the enrollment of the first patient in a Phase 3 randomized clinical trial (PDX-017) evaluating FOLOTYN in patients with previously undiagnosed peripheral T-cell lymphoma.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.
› Verified 6 days ago
Entity Name | Healthtexas Provider Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.
Researchers have found that children with achromatopsia have milder foveal pathology than their older counterparts, highlighting a potential opportunity for early intervention with gene therapy.
Allos Therapeutics, Inc. today announced the enrollment of the first patient in a Phase 3 randomized clinical trial (PDX-017) evaluating FOLOTYN in patients with previously undiagnosed peripheral T-cell lymphoma.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.
› Verified 6 days ago
Entity Name | Taylor Hm Physician Services, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386090728 PECOS PAC ID: 3779872122 Enrollment ID: O20160525001299 |
News Archive
The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.
Researchers have found that children with achromatopsia have milder foveal pathology than their older counterparts, highlighting a potential opportunity for early intervention with gene therapy.
Allos Therapeutics, Inc. today announced the enrollment of the first patient in a Phase 3 randomized clinical trial (PDX-017) evaluating FOLOTYN in patients with previously undiagnosed peripheral T-cell lymphoma.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Faheem Mohammed Haq, MD 1901 N Macarthur Blvd, Irving, TX 75061-2220 Ph: (972) 579-8485 | Dr Faheem Mohammed Haq, MD 1901 N Macarthur Blvd, Irving, TX 75061-2220 Ph: (972) 579-8485 |
News Archive
The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.
Researchers have found that children with achromatopsia have milder foveal pathology than their older counterparts, highlighting a potential opportunity for early intervention with gene therapy.
Allos Therapeutics, Inc. today announced the enrollment of the first patient in a Phase 3 randomized clinical trial (PDX-017) evaluating FOLOTYN in patients with previously undiagnosed peripheral T-cell lymphoma.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.
› Verified 6 days ago
Dr. Padmavathy Uppalapati, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1110 Cottonwood Ln, Suite 105, Irving, TX 75038 Phone: 972-607-2525 Fax: 972-252-8837 | |
Rupal Chiniwala, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6750 N Macarthur Blvd, Suite 150, Irving, TX 75039 Phone: 972-373-0303 Fax: 972-373-8074 | |
Dr. Harikrishna Raja, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 440 W Lyndon B Johnson Fwy Ste 405, Irving, TX 75063 Phone: 972-993-5080 Fax: 972-993-5081 | |
Dr. Deepika Alavala Reddy, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 N Macarthur Blvd, Irving, TX 75061 Phone: 972-579-8100 Fax: 972-579-3972 | |
Mrs. Devyani V Deshpande, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7200 N State Hwy 161, Suite 220, Irving, TX 75039 Phone: 214-689-7806 Fax: 214-689-5970 | |
Dr. Sarju Waghela, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 N Macarthur Blvd, #630, Irving, TX 75061 Phone: 972-256-3537 Fax: 972-255-7916 | |
Nauman Siddiqi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1110 Cottonwood Ln, # 105, Irving, TX 75038 Phone: 972-607-2525 |